IHC identified a loss of MLH1 and/or MSH2 expression in a total of 207 patients (10.2%); 106 patients (5.2%) were MLH1 negative and MSH2 positive, 85 patients (4.2%) were MLH1 positive and MSH2 ...

Monoallelic loss of PTEN and ARID1A is identified in normal colonic epithelium. The resulting haploinsufficient phenotypes ...

Lunit’s model demonstrated 86.7% accuracy compared to pathologist assessments for HER2 immunohistochemistry ... with HER2-positive metastatic colorectal cancer,” added NCCHE deputy director ...

Dr Nwokwu further said that, in collaboration with the World Health Organisation (WHO), the Federal Ministry of Health has developed awareness materials on childhood cancer. These materials will be ...

Histology and immunohistochemistry ... All cases of human colorectal adenomas (n=26), HD and adenocarcinoma arising in adenomatous polyps (n=24), invasive adenocarcinomas (n=33) and metastasis ...

Mechanisms of the spread of Krukenberg tumor proposed are retrograde lymphatic dissemination involved in gastric cancer metastases, hematogenous spread most frequent in colorectal cancer ... in the ...

Of which, ICC-based approaches are consist of immunofluorescence and immunohistochemistry technology ... and the potential clinical applications of CTCs in gastric and colorectal cancer. Although the ...

A new study led by Mass General Brigham researchers found it may also have protective benefits against a certain type of aggressive colon cancer. Study authors analyzed data totaling over 150,000 ...

Symptoms of colon cancer (also called colorectal cancer) are the same for everyone, regardless of a person’s sex or gender. There are no symptoms specific to women. It’s worth noting that some ...

Companion Diagnostics Market Companion Diagnostics Market Dublin, Feb. 13, 2025 (GLOBE NEWSWIRE) -- The "Companion ...

Lopez saw the scan and couldn't believe his eyes. Colon cancer? He was so young, healthy, and fit. Stories like Lopez's are increasingly common. Colon cancer rates are rocketing among athletic ...